Çmimi dhe lajme për fondin e përbashkët American Funds 2050 Target Date Retirement Fund® Class R-5 (REITX)

Faqja kryesoreREITX • Fond i përbashkët

American Funds 2050 Target Date Retirement Fund® Class R-5

24,14 USD

20 jan · USD · MUTF · Mohimi i përgjegjësisë

American Funds 2050 Target Date Retirement Fund® Class R-6

24,04 USD

RFITX1,64%

American Funds 2050 Target Date Retirement Fund® Class R-2

23,07 USD

RBITX1,66%

American Funds 2050 Target Date Retirement Fund® Class R-1

23,08 USD

RAITX1,66%

American Funds 2050 Target Date Retirement Fund® Class R-4

23,79 USD

RDITX1,65%

American Funds 2050 Target Date Retirement Fund® Class R-3

23,46 USD

RCITX1,64%

American Funds 2050 Target Date Retirement Fund® Class F-3

23,92 USD

DITFX1,60%

American Funds 2050 Target Date Retirement Fund® Class F-2

23,84 USD

FBITX1,61%

American Funds 2050 Target Date Retirement Fund® Class F-1

23,62 USD

FAITX1,67%

American Funds 2050 Target Date Retirement Fund® Class R-2E

23,29 USD

RBHEX1,65%

American Funds 2050 Target Date Retirement Fund® Class A

23,84 USD

AALTX1,65%

Fond i përbashkët

Mbyllja e fundit

24,54 USD

Deklarata e fitimit nga fillimi i vitit deri në momentin aktual

20,40%

Raporti i shpenzimit

0,42%

Kategoria

Target Date

Vlerësimi i Morningstar

Aktive neto

479,25 mln USD

Rendimenti

0,87%

Parapagesa

Data e fillimit

1 shk 2007

Lajmet nga tregu

CNBC

2 orë më parë

The S&P 500 and 10-year yield pain levels that could cause Trump to rethink Greenland push

.INX

1,15%

Investor's Business Daily

2 orë më parë

Stock Market Today: Dow Rises On Trump Pledge; Nvidia CEO Flags AI Investment Growth (Live Coverage)

AP News

17 minuta më parë

Trump cancels tariff threat over Greenland, says NATO agreed to 'framework' of future Arctic deal

MSN

1 orë më parë

This electronics maker crushed earnings. It’s one of the S&P 500’s top stocks today.

Dow surges 700 points after Trump announces Greenland framework, calls off tariff threat

MRNA is S&P 500’s top performing stock, here are the best Quant pharma companies